atracurium besylate
Generic: atracurium besylate
Labeler: hospira, inc.Drug Facts
Product Profile
Brand Name
atracurium besylate
Generic Name
atracurium besylate
Labeler
hospira, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
atracurium besylate 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0409-1105
Product ID
0409-1105_926d60c7-8585-42f2-a9fc-02fcb51dc2ae
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090761
Listing Expiration
2026-12-31
Marketing Start
2013-05-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04091105
Hyphenated Format
0409-1105
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
atracurium besylate (source: ndc)
Generic Name
atracurium besylate (source: ndc)
Application Number
ANDA090761 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "926d60c7-8585-42f2-a9fc-02fcb51dc2ae", "openfda": {"unii": ["40AX66P76P"], "rxcui": ["966768", "1718913"], "spl_set_id": ["de1c2dcd-295b-47ce-b7a1-a8be59939a54"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22)", "package_ndc": "0409-1105-02", "marketing_start_date": "20130529"}], "brand_name": "Atracurium Besylate", "product_id": "0409-1105_926d60c7-8585-42f2-a9fc-02fcb51dc2ae", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "0409-1105", "generic_name": "ATRACURIUM BESYLATE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atracurium Besylate", "active_ingredients": [{"name": "ATRACURIUM BESYLATE", "strength": "10 mg/mL"}], "application_number": "ANDA090761", "marketing_category": "ANDA", "marketing_start_date": "20130529", "listing_expiration_date": "20261231"}